These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 23378357)

  • 1. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement.
    Leung WK; Ng SC; Chow DK; Lao WC; Leung VK; Li MK; Hui YT; Ng SS; Hui AJ; Lai ST; Lam JT; Poon JT; Chan AO; Yuen H; Wu JC; ;
    Hong Kong Med J; 2013 Feb; 19(1):61-8. PubMed ID: 23378357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements.
    Wu JC; Chan AO; Chan YW; Cheung GC; Cheung TK; Kwan AC; Leung VK; Mak AD; Sze WC; Wong R
    Hong Kong Med J; 2017 Dec; 23(6):641-7. PubMed ID: 29226832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus statements on adherence issues in schizophrenia for Hong Kong.
    Mak KY; Lo WT; Yeung WS; Wong M; Chung WS; Chui E; Tam KL; Hui LK; Mui J; Chan OW; Wong KL
    Asian J Psychiatr; 2014 Dec; 12():163-9. PubMed ID: 25440570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
    Cheifetz AS; Abreu MT; Afif W; Cross RK; Dubinsky MC; Loftus EV; Osterman MT; Saroufim A; Siegel CA; Yarur AJ; Melmed GY; Papamichael K
    Am J Gastroenterol; 2021 Oct; 116(10):2014-2025. PubMed ID: 34388143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    Poon DM; Chan CK; Chan TW; Cheung FY; Kwong PW; Lee EK; Leung AK; Leung SY; Ma WK; So HS; Tam PC; Ho LY
    BJU Int; 2018 May; 121(5):703-715. PubMed ID: 29211320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
    Papamichael K; Cheifetz AS; Melmed GY; Irving PM; Vande Casteele N; Kozuch PL; Raffals LE; Baidoo L; Bressler B; Devlin SM; Jones J; Kaplan GG; Sparrow MP; Velayos FS; Ullman T; Siegel CA
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1655-1668.e3. PubMed ID: 30928454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong.
    Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Tam KL; Mak KY
    Intern Med J; 2020 Sep; 50 Suppl 3():6-14. PubMed ID: 32985093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Ma WK; Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Kwong PW
    BJU Int; 2019 Aug; 124(2):221-241. PubMed ID: 30653801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.
    Poon DM; Chan CK; Chan K; Chu WH; Kwong PW; Lam W; Law KS; Lee EK; Liu PL; Sze HC; Wong JH; Chan ES
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():27-38. PubMed ID: 33860644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements.
    Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Mak KY
    CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):5-11. PubMed ID: 33555614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
    Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW;
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1037-1053. PubMed ID: 29027257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus statement on ischaemic stroke care in Hong Kong.
    Ng PW; Huang CY; Cheung RT; Wong KS; Wong CK; Lam JM; ;
    Hong Kong Med J; 2004 Apr; 10(2):124-9. PubMed ID: 15075433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the management of advanced and metastatic renal cell carcinoma: joint consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Poon DMC; Chan CK; Chan K; Chu WH; Kwong PWK; Lam W; Law KS; Lee EKC; Liu PL; Sze HCK; Wong JHM; Chan ESY
    Hong Kong Med J; 2022 Dec; 28(6):475-481. PubMed ID: 35815480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus statements on the clinical uses of pregabalin for Hong Kong.
    Kwong PP; Chan EY; Cheung EY; Fong SY; Nip W; Cheung HH; Yip IP; Chong KY; Pao RS; Tam KL; Tang MH; Chan SK; Mak KY
    Asia Pac Psychiatry; 2020 Sep; 12(3):e12403. PubMed ID: 32830438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
    Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statements on the clinical understanding and use of bupropion in Hong Kong.
    Lee WK; Au Yeung KL; Lam HB; Wong CK; Wong TC; Fu CK; Sham SK; Au MK; Lam TC; Ki-Yan Mak D
    CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):20-24. PubMed ID: 33555615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statements on the clinical understanding and use of milnacipran in Hong Kong.
    Lee WK; Au Yeung KL; Lam HB; Wong CK; Au MK; Chan HYK; Cheung YWE; Chui WH; Wong TCV; Fu CK; Sham SK; Mak KY
    Hum Psychopharmacol; 2018 Mar; 33(2):e2651. PubMed ID: 29341261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    Chiu PKF; Lee EKC; Chan MTY; Chan WHC; Cheung MH; Lam MHC; Ma ESK; Poon DMC
    Front Oncol; 2022; 12():962958. PubMed ID: 35924163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus.
    Guillo L; Delanaye P; Flamant M; Figueres L; Karam S; Lemoine S; Benezech A; Pelletier AL; Amiot A; Caron B; Stefanescu C; Boschetti G; Bouguen G; Rahier JF; Gornet JM; Hugot JP; Bonnet J; Vuitton L; Nachury M; Vidon M; Uzzan M; Serrero M; Dib N; Seksik P; Hebuterne X; Bertocchio JP; Mariat C; Peyrin-Biroulet L
    Dig Liver Dis; 2022 Mar; 54(3):309-315. PubMed ID: 34866011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.